Risk for all-cause mortality and MACEs are affected by calcified and low-attenuation plaque burdens in patients with chronic kidney disease.

The global angiography devices market is experiencing significant growth, driven by technological advancements in medical devices and the rising prevalence of cardiovascular diseases worldwide.

Cardiac imaging consists of taking pictures of the heart and surrounding structures. It helps physicians learn more about a ...

WE LIVE in an era where technological advancements in medical imaging have transformed the way doctors diagnose diseases, ...

The angiography devices market plays a pivotal role in modern medicine, particularly in the diagnosis and treatment of ...

Geographically, North America witnesses the high pervasiveness of cancer, stroke, bone cancer, and fractures, which makes the region, highest contributor to the growth of the global multimodal imaging ...

Cleerly, a leader in advanced cardiovascular imaging, is excited to announce its participation in the Radiological Society of North America (RSNA) Conference and Annual Meeting, taking place from ...

OhioHealth Berger Hospital has launched advanced Cardiac Computed Tomography Angiography (CCTA) technology, providing a ...

Dual and multi-energy CT technologies offer enhanced diagnostic capabilities by providing detailed tissue characterization ...

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily ...

Of these patients, 452 were screened with a coronary computed tomography angiography (CCTA), which uses a powerful X-ray to make a 3D image of the heart. Researchers compared these patients with a ...

Colchicine, a medication with well-documented anti-inflammatory action and with an impact on reducing cardiovascular outcomes, may influence reducing FAI (Fat Attenuation index) assessed by coronary ...